Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole

Joseph E Tietge1, Sigmund J Degitz, Jonathan T Haselman

  • 1US Environmental Protection Agency, Office of Research and Development, National Health and Environmental Effects Research Laboratory, Mid-Continent Ecology Division, Duluth, MN 55804, United States. tietge.joe@epa.gov

Insights

2-Mercaptobenzothiazole (MBT) disrupts the thyroid system by inhibiting thyroid peroxidase (TPO) enzyme activity. This chemical safety evaluation in Xenopus laevis larvae confirms MBT as a thyroid disruptor, supporting tiered testing approaches.

Area of Science:

  • Endocrinology
  • Environmental Toxicology
  • Chemical Safety Assessment

Background:

  • Evaluating chemical safety requires understanding endocrine-disrupting effects on the thyroid system.
  • Prioritizing high-production volume chemicals for in vivo testing is crucial due to limited resources.
  • 2-Mercaptobenzothiazole (MBT) was identified as a potential thyroid disruptor due to in vitro inhibition of thyroid peroxidase (TPO).

Purpose of the Study:

  • To determine the in vivo thyroid-disrupting activity of 2-Mercaptobenzothiazole (MBT).
  • To validate the predictive potential of in vitro thyroid peroxidase (TPO) inhibition assays for in vivo chemical safety assessments.
  • To establish a tiered approach for prioritizing chemicals for endocrine disruption testing.

Main Methods:

  • Xenopus laevis larvae were exposed to MBT using 7-day and 21-day protocols with varying concentrations.
  • Endpoints evaluated included metamorphic development, thyroid histology, circulating thyroid hormones (T4, T3), and thyroidal gene expression (sodium-iodide symporter).
  • The 7-day protocol provided comprehensive data on intermediate biological levels, linking various endpoints in a thyroid hormone disruption pathway.

Main Results:

  • Both 7-day and 21-day exposure protocols demonstrated that MBT is a thyroid-disrupting chemical at the lowest tested concentrations.
  • MBT exposure led to significant effects on thyroid hormone synthesis and regulation.
  • The 7-day study successfully linked molecular and physiological endpoints, supporting a pathway for MBT-induced thyroid disruption via TPO inhibition.

Conclusions:

  • 2-Mercaptobenzothiazole (MBT) is confirmed as an in vivo thyroid-disrupting chemical.
  • The findings support the utility of in vitro TPO inhibition assays for prioritizing chemicals for further testing.
  • A tiered testing strategy, integrating in vitro and in vivo data, is effective for evaluating chemical safety and endocrine disruption potential.